Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1947 1
1950 3
1951 1
1952 3
1954 3
1955 2
1956 2
1957 1
1961 2
1962 1
1963 5
1964 4
1965 1
1966 6
1968 4
1969 3
1970 2
1971 1
1972 2
1973 2
1974 2
1975 3
1976 10
1977 2
1978 8
1979 9
1980 6
1981 10
1982 7
1983 12
1984 13
1985 10
1986 6
1987 8
1988 15
1989 13
1990 17
1991 18
1992 18
1993 24
1994 19
1995 27
1996 27
1997 32
1998 33
1999 38
2000 32
2001 39
2002 56
2003 59
2004 66
2005 69
2006 74
2007 87
2008 79
2009 91
2010 117
2011 117
2012 116
2013 120
2014 131
2015 106
2016 134
2017 159
2018 166
2019 154
2020 149
2021 86
Text availability
Article attribute
Article type
Publication date

Search Results

2,415 results
Results by year
Filters applied: . Clear all
Page 1
The spectrum of intermediate SCN8A-related epilepsy.
Johannesen KM, Gardella E, Encinas AC, Lehesjoki AE, Linnankivi T, Petersen MB, Lund ICB, Blichfeldt S, Miranda MJ, Pal DK, Lascelles K, Procopis P, Orsini A, Bonuccelli A, Giacomini T, Helbig I, Fenger CD, Sisodiya SM, Hernandez-Hernandez L, Krithika S, Rumple M, Masnada S, Valente M, Cereda C, Giordano L, Accorsi P, Bürki SE, Mancardi M, Korff C, Guerrini R, von Spiczak S, Hoffman-Zacharska D, Mazurczak T, Coppola A, Buono S, Vecchi M, Hammer MF, Varesio C, Veggiotti P, Lal D, Brünger T, Zara F, Striano P, Rubboli G, Møller RS. Johannesen KM, et al. Among authors: miranda mj. Epilepsia. 2019 May;60(5):830-844. doi: 10.1111/epi.14705. Epub 2019 Apr 10. Epilepsia. 2019. PMID: 30968951
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2.
Walls AC, Fiala B, Schäfer A, Wrenn S, Pham MN, Murphy M, Tse LV, Shehata L, O'Connor MA, Chen C, Navarro MJ, Miranda MC, Pettie D, Ravichandran R, Kraft JC, Ogohara C, Palser A, Chalk S, Lee EC, Guerriero K, Kepl E, Chow CM, Sydeman C, Hodge EA, Brown B, Fuller JT, Dinnon KH 3rd, Gralinski LE, Leist SR, Gully KL, Lewis TB, Guttman M, Chu HY, Lee KK, Fuller DH, Baric RS, Kellam P, Carter L, Pepper M, Sheahan TP, Veesler D, King NP. Walls AC, et al. Among authors: miranda mc. Cell. 2020 Nov 25;183(5):1367-1382.e17. doi: 10.1016/j.cell.2020.10.043. Epub 2020 Oct 31. Cell. 2020. PMID: 33160446 Free PMC article.
Lactate dehydrogenase activity drives hair follicle stem cell activation.
Flores A, Schell J, Krall AS, Jelinek D, Miranda M, Grigorian M, Braas D, White AC, Zhou JL, Graham NA, Graeber T, Seth P, Evseenko D, Coller HA, Rutter J, Christofk HR, Lowry WE. Flores A, et al. Among authors: miranda m. Nat Cell Biol. 2017 Sep;19(9):1017-1026. doi: 10.1038/ncb3575. Epub 2017 Aug 14. Nat Cell Biol. 2017. PMID: 28812580 Free PMC article.
Biological Activities of Red Propolis: A Review.
de Freitas MCD, de Miranda MB, de Oliveira DT, Vieira-Filho SA, Caligiorne RB, de Figueiredo SM. de Freitas MCD, et al. Among authors: de miranda mb. Recent Pat Endocr Metab Immune Drug Discov. 2017;11(1):3-12. doi: 10.2174/1872214812666180223120316. Recent Pat Endocr Metab Immune Drug Discov. 2017. PMID: 29473533 Review.
A systematic review of psychoneuroimmunology-based interventions.
Moraes LJ, Miranda MB, Loures LF, Mainieri AG, Mármora CHC. Moraes LJ, et al. Among authors: miranda mb. Psychol Health Med. 2018 Jul;23(6):635-652. doi: 10.1080/13548506.2017.1417607. Epub 2017 Dec 20. Psychol Health Med. 2018. PMID: 29262731
[Treatment of rolandic epilepsy].
Miranda MJ, Ahmad BB. Miranda MJ, et al. Ugeskr Laeger. 2017 Nov 27;179(48):V06170482. Ugeskr Laeger. 2017. PMID: 29208197 Review. Danish.
Structure and Distribution of an Unrecognized Interstitium in Human Tissues.
Benias PC, Wells RG, Sackey-Aboagye B, Klavan H, Reidy J, Buonocore D, Miranda M, Kornacki S, Wayne M, Carr-Locke DL, Theise ND. Benias PC, et al. Among authors: miranda m. Sci Rep. 2018 Mar 27;8(1):4947. doi: 10.1038/s41598-018-23062-6. Sci Rep. 2018. PMID: 29588511 Free PMC article.
Osimertinib versus platinum-pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis.
Papadimitrakopoulou VA, Mok TS, Han JY, Ahn MJ, Delmonte A, Ramalingam SS, Kim SW, Shepherd FA, Laskin J, He Y, Akamatsu H, Theelen WSME, Su WC, John T, Sebastian M, Mann H, Miranda M, Laus G, Rukazenkov Y, Wu YL. Papadimitrakopoulou VA, et al. Among authors: miranda m. Ann Oncol. 2020 Nov;31(11):1536-1544. doi: 10.1016/j.annonc.2020.08.2100. Epub 2020 Aug 27. Ann Oncol. 2020. PMID: 32861806 Free article. Clinical Trial.
2,415 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page